My Retina Tracker Program
Use
The My Retina Tracker Program provides no‑cost genetic testing and counseling for individuals with a clinically confirmed inherited retinal disease (IRD). It uses a comprehensive 110‑gene panel to help identify pathogenic variants associated with retinal dystrophies and facilitate cascade testing, prognostic insights, and eligibility for therapies or trials. A familial variant testing option is available at no cost for qualifying biological relatives when a positive or indeterminate result has been returned in a family member. Participation also requires willingness to join the My Retina Tracker Registry and share the genetic results. ([preventiongenetics.com](https://www.preventiongenetics.com//sponsoredTesting/ffb-my-retina-tracker?utm_source=openai))
Special Instructions
Eligibility criteria include residence in the U.S. or its territories, a confirmed IRD diagnosis, no first‑degree relatives previously tested by the Program, no prior large‑panel IRD testing (≥32 genes), exome or genome sequencing, or IRD molecular diagnosis in the past 5 years. Applicants must enroll via an application process through the Foundation Fighting Blindness, complete and submit consent and HIPAA forms electronically, and providers must order via the Program‑specific portal. Post‑test genetic counseling is provided at no charge via InformedDNA. ([preventiongenetics.com](https://www.preventiongenetics.com//sponsoredTesting/ffb-my-retina-tracker?utm_source=openai))
Limitations
This is a targeted panel limited to the 110 specified genes; it does not include whole exome or whole genome sequencing. Prior testing with panels of ≥32 IRD‑related genes within 5 years, exome/genome sequencing, or prior molecular diagnosis disqualifies participation. Saliva specimens may be contaminated with microbial/food DNA, potentially impacting quality and leading to delays or need for recollection. ([preventiongenetics.com](https://www.preventiongenetics.com//sponsoredTesting/ffb-my-retina-tracker?utm_source=openai))
Methodology
NGS (Targeted)
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
3–5 ml
Minimum Volume
Not provided
Container
EDTA (purple top) or ACD (yellow top) tube
Collection Instructions
Collect 3 ml to 5 ml of whole blood in EDTA (purple top tube) or ACD (yellow top tube). Label with at least two identifiers.